Carl I. Schwartz, Chief Executive Officer, 10% Owner at Predictive Oncology Inc. (POAI), sold 640 shares at $0.85 ($544) on 2020-10-22, disclosed to the SEC on 2020-10-26.
Scheduled sale ($544) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SGLB | BUY | 2019-05-24 | $560K | — | Filing → |
| AIPT | BUY | 2019-01-17 | $50K | — | Filing → |
| SGLB | BUY | 2018-09-04 | $922K | — | Filing → |